Two Sigma Investments’s Syros Pharmaceuticals, Inc. Common Stock SYRS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q1
Sell
-48,861
Closed -$11.2K 3514
2024
Q4
$11.2K Buy
48,861
+20,386
+72% +$4.69K ﹤0.01% 3063
2024
Q3
$61.2K Sell
28,475
-11,791
-29% -$25.4K ﹤0.01% 2890
2024
Q2
$208K Sell
40,266
-28,017
-41% -$145K ﹤0.01% 2643
2024
Q1
$365K Buy
68,283
+13,629
+25% +$72.9K ﹤0.01% 2406
2023
Q4
$426K Buy
+54,654
New +$426K ﹤0.01% 2463
2023
Q3
Sell
-19,584
Closed -$61.7K 3193
2023
Q2
$61.7K Buy
19,584
+5,984
+44% +$18.9K ﹤0.01% 2724
2023
Q1
$36.3K Buy
13,600
+3,139
+30% +$8.38K ﹤0.01% 2715
2022
Q4
$37.6K Buy
+10,461
New +$37.6K ﹤0.01% 2562
2022
Q2
Sell
-18,637
Closed -$222K 2966
2022
Q1
$222K Buy
18,637
+13,770
+283% +$164K ﹤0.01% 2271
2021
Q4
$159K Sell
4,867
-4,261
-47% -$139K ﹤0.01% 2336
2021
Q3
$408K Sell
9,128
-2,907
-24% -$130K ﹤0.01% 2081
2021
Q2
$656K Sell
12,035
-9,003
-43% -$491K ﹤0.01% 1870
2021
Q1
$1.57M Buy
21,038
+7,135
+51% +$534K ﹤0.01% 1379
2020
Q4
$1.51M Sell
13,903
-1,448
-9% -$157K ﹤0.01% 1188
2020
Q3
$1.36M Sell
15,351
-9,349
-38% -$826K ﹤0.01% 1069
2020
Q2
$2.63M Buy
+24,700
New +$2.63M 0.01% 782
2020
Q1
Sell
-2,170
Closed -$150K 2488
2019
Q4
$150K Buy
+2,170
New +$150K ﹤0.01% 2016
2019
Q2
Sell
-1,854
Closed -$169K 2497
2019
Q1
$169K Sell
1,854
-2,922
-61% -$266K ﹤0.01% 1956
2018
Q4
$266K Sell
4,776
-932
-16% -$51.9K ﹤0.01% 1791
2018
Q3
$680K Sell
5,708
-6,004
-51% -$715K ﹤0.01% 1504
2018
Q2
$1.2M Buy
+11,712
New +$1.2M ﹤0.01% 1290
2018
Q1
Sell
-2,120
Closed -$206K 2413
2017
Q4
$206K Buy
2,120
+944
+80% +$91.7K ﹤0.01% 2027
2017
Q3
$173K Buy
+1,176
New +$173K ﹤0.01% 1799